Revenue ($USD) : $15,887,000,000
R&D spend : not available
Employees : not available
Fiscal year end : 06/30/22
CEO : Jason Hollar, CEO; Steve Mason, medical segment CEO

One of the most significant medical device stories out of Cardinal Health over the past 12 months involved the launch of a pilot supply chain network to enable hospital-level healthcare in people’s homes.

The Dublin, Ohio–based medical device and pharmaceuticals supplier announced in November 2022 that it was kicking off the Velocare supply chain network and last-mile fulfillment service through a strategic partnership with Boston-based Medically Home. (Cardinal Health is an investor in Medically Home.)

Since the launch, Cardinal Health at-Home Solutions has grown the offering to support several hospital-at-home programs around the country. Velocare is creating critical infrastructure and scalability to make hospital-at-home programs work and grow. It offers a wide range of needed medical products and supplies, oxygen or medical gas, technology, and medically approved meals. It also goes into patients’ homes to perform services, such as providing and installing technology and collecting and disposing medical waste. The goal is to enable safe and consistent hospital-level care in the home.

Overall, Cardinal Health continues to work on turning around its medical segment, which as of early August had seen declining revenue and profits this year. CEO Jason Hollar said in May: “In medical, we continue to see improvement in underlying performance and remain confident in our Medical Improvement Plan initiatives.” –CN